Healthcare provider profile · identity verified

Joseph Michael Lauinger

Internal Medicine · KENT, WA · NPI 1598840308

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	658	169
Amlodipine Besylate	Amlodipine Besylate	512	134
Rosuvastatin Calcium	Rosuvastatin Calcium	342	105
Levothyroxine Sodium	Levothyroxine Sodium	239	51
Tamsulosin Hcl	Tamsulosin Hcl	231	69
Mounjaro	Tirzepatide	217	42
Trazodone Hcl	Trazodone Hcl	183	44
Famotidine	Famotidine	181	37
Omeprazole	Omeprazole	181	37
Lisinopril	Lisinopril	175	58
Metoprolol Succinate	Metoprolol Succinate	164	55
Gabapentin	Gabapentin	146	43
Albuterol Sulfate Hfa	Albuterol Sulfate	133	51
Fluticasone Propionate	Fluticasone Propionate	133	42
Metformin Hcl	Metformin Hcl	133	34
Pantoprazole Sodium	Pantoprazole Sodium	124	28
Losartan Potassium	Losartan Potassium	123	33
Furosemide	Furosemide	119	34
Hydrochlorothiazide	Hydrochlorothiazide	113	30
Allopurinol	Allopurinol	111	19
Eliquis	Apixaban	108	29
Valsartan	Valsartan	104	29
Montelukast Sodium	Montelukast Sodium	98	15
Simvastatin	Simvastatin	97	35
Metformin Hcl Er	Metformin Hcl	94	21
Pregabalin	Pregabalin	94	17
Tramadol Hcl	Tramadol Hcl	84	16
Oxycodone Hcl	Oxycodone Hcl	83	13
Escitalopram Oxalate	Escitalopram Oxalate	79	22
Duloxetine Hcl	Duloxetine Hcl	73	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	72	26
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	63	19
Pioglitazone Hcl	Pioglitazone Hcl	60	18
Prednisone	Prednisone	60	22
Xarelto	Rivaroxaban	60	17
Methocarbamol	Methocarbamol	58	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	57	suppressed
Jardiance	Empagliflozin	57	15
Chlorhexidine Gluconate	Chlorhexidine Gluconate	55	suppressed
Sertraline Hcl	Sertraline Hcl	55	15
Ibuprofen	Ibuprofen	54	15
Propranolol Hcl	Propranolol Hcl	54	suppressed
Ondansetron Odt	Ondansetron	53	15
Pravastatin Sodium	Pravastatin Sodium	51	suppressed
Rybelsus	Semaglutide	51	12
Triamcinolone Acetonide	Triamcinolone Acetonide	50	27
Citalopram Hbr	Citalopram Hydrobromide	48	11
Carvedilol	Carvedilol	47	13
Ketoconazole	Ketoconazole	47	12
Atenolol	Atenolol	43	12
Potassium Chloride	Potassium Chloride	43	14
Alcohol Prep Pads	Alcohol Antiseptic Pads	40	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	40	11
Spironolactone	Spironolactone	40	12
Meloxicam	Meloxicam	38	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	suppressed
Clonidine Hcl	Clonidine Hcl	36	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	14
Telmisartan	Telmisartan	33	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Finasteride	Finasteride	31	suppressed
Mirtazapine	Mirtazapine	31	suppressed
Baclofen	Baclofen	30	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	15
Hydroxyzine Hcl	Hydroxyzine Hcl	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Azelastine Hcl	Azelastine Hcl	28	suppressed
Mupirocin	Mupirocin	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Glyxambi	Empagliflozin/Linagliptin	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	12
Topiramate	Topiramate	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	12
Celecoxib	Celecoxib	25	suppressed
Clotrimazole	Clotrimazole	25	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Colchicine	Colchicine	23	suppressed
Glipizide	Glipizide	23	suppressed
Prazosin Hcl	Prazosin Hcl	23	suppressed
Digoxin	Digoxin	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Estradiol	Estradiol	21	suppressed
Linzess	Linaclotide	21	suppressed
Olanzapine	Olanzapine	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Alprazolam	Alprazolam	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Ibandronate Sodium	Ibandronate Sodium	20	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	20	suppressed
Dilantin	Phenytoin Sodium Extended	19	suppressed
Lactulose	Lactulose	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Azithromycin	Azithromycin	18	15
Buspirone Hcl	Buspirone Hcl	18	suppressed
Felodipine Er	Felodipine	18	suppressed
Norethindron-Ethinyl Estradiol	Norethindrone Ac/Eth Estradiol	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Doxepin Hcl	Doxepin Hcl	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Glipizide Er	Glipizide	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Clonazepam	Clonazepam	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Icosapent Ethyl	Icosapent Ethyl	12	suppressed
Levocarnitine	Levocarnitine	12	suppressed
Naproxen	Naproxen	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error